Word: pfizer
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Pfizer...
...professor of law at Duke Law School who specializes in patent law and the biopharmaceutical industry, said yesterday that a win for the plaintiffs would be a “long shot.” She cited an unsuccessful patent claim brought by the University of Rochester against Pfizer and Pharmacia in 2000. A win for Ariad and the co-plaintiffs, Rai said, would favor patent holders making claims on other drugs that use the same signaling pathways to a particular molecule. According to Science magazine, a recent paper said more than 200 compounds use NF-kB signaling, aspirin among...
...defense cells specifically designed to attack varicella. In trials with nearly 40,000 subjects, the vaccine reduced rash and pain from shingles by more than 60% in elderly adults. ?AIDS Doctors are close to adding one more powerful ingredient to their antiviral recipe against AIDS. Researchers at Pfizer have developed the first in a new class of compounds that would prevent HIV from entering and infecting a healthy cell. So far, the medications that have saved millions of AIDS patients around the world have thwarted HIV at the end of its reproductive cycle; Pfizer's compound, a once...
...make it from the lab to the pharmacy. Here are some of the latest candidates, either just approved by the Food and Drug Administration (FDA) or under review. ?DIABETES If you're a diabetic and the daily injections of insulin are torture, then get ready for some relief. Pfizer received FDA approval in January to market the first inhaled insulin, Exubera, which should become available around midyear. The powdered insulin, taken just before meals, is released into the mouth and lungs through an inhaler similar to the ones that asthma patients use. In studies of more than...
...churn out more HDL. They also have an added incentive to prescribe the powerful statin drugs that lower LDL because those appear to do double duty, pumping up HDL levels 10% to 15%. And if that isn't enough, they are eyeing the arrival of HDL-boosting pills: Pfizer's torcetrapib is currently in clinical trials in combination with a statin and could be ready for FDA review in a year or two. "It's a look into the future of heart care," says Dr. Roger Blumenthal, director of Johns Hopkins Hospital's preventive cardiology program, of the new focus...